Build Your Comparison

Side-by-side financial analysis
PROV logo
PROV
ICE logo
ICE
CME logo
CME
WAFD logo
WAFD
NDAQ logo
NDAQ
Try popular comparisons:

Stock Comparison

PROV vs ICE vs CME vs WAFD vs NDAQ

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PROV
Provident Financial Holdings, Inc.

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$109M
5Y Perf.+27.6%
ICE
Intercontinental Exchange, Inc.

Financial - Data & Stock Exchanges

Financial ServicesNYSE • US
Market Cap$79.60B
5Y Perf.+53.4%
CME
CME Group Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$97.79B
5Y Perf.+65.8%
WAFD
WaFd, Inc.

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$2.85B
5Y Perf.+38.1%
NDAQ
Nasdaq, Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$50.58B
5Y Perf.+123.5%

PROV vs ICE vs CME vs WAFD vs NDAQ — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PROV logoPROV
ICE logoICE
CME logoCME
WAFD logoWAFD
NDAQ logoNDAQ
IndustryBanks - RegionalFinancial - Data & Stock ExchangesFinancial - Data & Stock ExchangesBanks - RegionalFinancial - Data & Stock Exchanges
Market Cap$109M$79.60B$97.79B$2.85B$50.58B
Revenue (TTM)$60M$12.64B$6.76B$1.39B$8.27B
Net Income (TTM)$7M$3.30B$4.24B$243M$1.91B
Gross Margin67.8%61.9%86.3%52.8%54.8%
Operating Margin16.2%38.7%65.6%22.4%29.5%
Forward P/E15.4x17.3x22.0x11.4x22.6x
Total Debt$213M$20.28B$3.76B$1.82B$9.93B
Cash & Equiv.$53M$837M$4.42B$657M$814M

PROV vs ICE vs CME vs WAFD vs NDAQLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PROV
ICE
CME
WAFD
NDAQ
StockJun 20Jun 26Return
Provident Financial… (PROV)100127.6+27.6%
Intercontinental Ex… (ICE)100153.4+53.4%
CME Group Inc. (CME)100165.8+65.8%
WaFd, Inc. (WAFD)100138.1+38.1%
Nasdaq, Inc. (NDAQ)100223.5+123.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: PROV vs ICE vs CME vs WAFD vs NDAQ

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NDAQ leads in 3 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. Provident Financial Holdings, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. CME and WAFD also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
🥇NDAQ emerged as the overall leader. Track its performance:
PROV
Provident Financial Holdings, Inc.
The Banking Pick

PROV is the #2 pick in this set and the best alternative if defensive and bank quality is your priority.

  • Beta 0.21, yield 3.3%, current ratio 0.06x
  • NIM 2.8% vs WAFD's 2.5%
  • Lower P/E (15.4x vs 22.6x)
  • Beta 0.21 vs NDAQ's 0.71
Best for: defensive and bank quality
ICE
Intercontinental Exchange, Inc.
The Banking Pick

ICE is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 0.35, Low D/E 69.9%, current ratio 1.02x
Best for: sleep-well-at-night
CME
CME Group Inc.
The Banking Pick

CME ranks third and is worth considering specifically for valuation efficiency.

  • PEG 1.60 vs WAFD's 3.69
  • 4.1% yield, 15-year raise streak, vs WAFD's 2.8%
Best for: valuation efficiency
WAFD
WaFd, Inc.
The Banking Pick

WAFD is the clearest fit if your priority is income & stability.

  • Dividend streak 16 yrs, beta 0.66, yield 2.8%
  • +32.5% vs ICE's -20.4%
Best for: income & stability
NDAQ
Nasdaq, Inc.
The Banking Pick

NDAQ carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 11.1%, EPS growth 60.1%
  • 344.3% 10Y total return vs CME's 262.4%
  • 11.1% NII/revenue growth vs WAFD's -1.6%
  • Efficiency ratio 0.2% vs PROV's 0.5% (lower = leaner)
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthNDAQ logoNDAQ11.1% NII/revenue growth vs WAFD's -1.6%
ValuePROV logoPROVLower P/E (15.4x vs 22.6x)
Quality / MarginsNDAQ logoNDAQEfficiency ratio 0.2% vs PROV's 0.5% (lower = leaner)
Stability / SafetyPROV logoPROVBeta 0.21 vs NDAQ's 0.71
DividendsCME logoCME4.1% yield, 15-year raise streak, vs WAFD's 2.8%
Momentum (1Y)WAFD logoWAFD+32.5% vs ICE's -20.4%
Efficiency (ROA)NDAQ logoNDAQEfficiency ratio 0.2% vs PROV's 0.5%

PROV vs ICE vs CME vs WAFD vs NDAQ — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Fintech Stocks Theme

These companies are key players in the Fintech Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
PROVProvident Financial Holdings, Inc.
FY 2025
Debit Card
53.2%$1M
Deposit Account
46.8%$1M
ICEIntercontinental Exchange, Inc.
FY 2025
Fixed Income And Data Services Segment
51.1%$1.4B
Exchanges Segment
38.8%$1.0B
Mortgage Technology Segment
10.1%$269M
CMECME Group Inc.
FY 2025
clearing and transaction fees
81.0%$5.3B
MarketData
12.3%$803M
OtherRevenue
6.7%$436M
WAFDWaFd, Inc.

Segment breakdown not available.

NDAQNasdaq, Inc.
FY 2025
Market Services
51.4%$4.2B
Capital Access Platforms
26.1%$2.1B
Market Technology
22.6%$1.9B

PROV vs ICE vs CME vs WAFD vs NDAQ — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCMELAGGINGWAFD

Income & Cash Flow (Last 12 Months)

CME leads this category, winning 4 of 5 comparable metrics.

ICE is the larger business by revenue, generating $12.6B annually — 210.1x PROV's $60M. CME is the more profitable business, keeping 62.8% of every revenue dollar as net income compared to PROV's 11.0%.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …CME logoCMECME Group Inc.WAFD logoWAFDWaFd, Inc.NDAQ logoNDAQNasdaq, Inc.
RevenueTrailing 12 months$60M$12.6B$6.8B$1.4B$8.3B
EBITDAEarnings before interest/tax$12M$6.5B$4.7B$277M$3.1B
Net IncomeAfter-tax profit$7M$3.3B$4.2B$243M$1.9B
Free Cash FlowCash after capex$9M$4.3B$4.4B$215M$2.0B
Gross MarginGross profit ÷ Revenue+67.8%+61.9%+86.3%+52.8%+54.8%
Operating MarginEBIT ÷ Revenue+16.2%+38.7%+65.6%+22.4%+29.5%
Net MarginNet income ÷ Revenue+11.0%+26.1%+62.8%+17.5%+23.1%
FCF MarginFCF ÷ Revenue+15.3%+33.9%+64.4%+15.5%+24.2%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+69.2%+23.1%+21.4%+46.3%+33.8%
CME leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

Evenly matched — PROV and WAFD each lead in 3 of 7 comparable metrics.

At 14.1x trailing earnings, WAFD trades at a 51% valuation discount to NDAQ's 28.8x P/E. Adjusting for growth (PEG ratio), CME offers better value at 1.76x vs WAFD's 4.58x — a lower PEG means you pay less per unit of expected earnings growth.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …CME logoCMECME Group Inc.WAFD logoWAFDWaFd, Inc.NDAQ logoNDAQNasdaq, Inc.
Market CapShares × price$109M$79.6B$97.8B$2.9B$50.6B
Enterprise ValueMkt cap + debt − cash$269M$99.0B$97.1B$4.0B$59.7B
Trailing P/EPrice ÷ TTM EPS18.40x24.36x24.15x14.10x28.80x
Forward P/EPrice ÷ next-FY EPS est.15.41x17.34x21.98x11.35x22.60x
PEG RatioP/E ÷ EPS growth rate2.74x1.76x4.58x2.69x
EV / EBITDAEnterprise value multiple21.77x15.34x21.56x13.41x20.14x
Price / SalesMarket cap ÷ Revenue1.81x6.30x15.00x2.02x6.15x
Price / BookPrice ÷ Book value/share0.90x2.77x3.38x0.98x4.19x
Price / FCFMarket cap ÷ FCF13.38x18.56x23.32x13.71x25.43x
Evenly matched — PROV and WAFD each lead in 3 of 7 comparable metrics.

Profitability & Efficiency

Evenly matched — CME and NDAQ each lead in 4 of 9 comparable metrics.

NDAQ delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $5 for PROV. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to PROV's 1.66x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs CME's 5/9, reflecting strong financial health.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …CME logoCMECME Group Inc.WAFD logoWAFDWaFd, Inc.NDAQ logoNDAQNasdaq, Inc.
ROE (TTM)Return on equity+5.1%+11.6%+15.3%+8.0%+15.9%
ROA (TTM)Return on assets+0.5%+2.3%+2.2%+0.9%+6.4%
ROICReturn on invested capital+1.9%+7.5%+10.2%+3.9%+8.1%
ROCEReturn on capital employed+2.4%+9.5%+3.6%+5.7%+10.2%
Piotroski ScoreFundamental quality 0–969579
Debt / EquityFinancial leverage1.66x0.70x0.13x0.60x0.81x
Net DebtTotal debt minus cash$160M$19.4B-$666M$1.2B$9.1B
Cash & Equiv.Liquid assets$53M$837M$4.4B$657M$814M
Total DebtShort + long-term debt$213M$20.3B$3.8B$1.8B$9.9B
Interest CoverageEBIT ÷ Interest expense0.47x6.53x41.55x0.48x14.11x
Evenly matched — CME and NDAQ each lead in 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

NDAQ leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in NDAQ five years ago would be worth $16,022 today (with dividends reinvested), compared to $11,816 for PROV. Over the past 12 months, WAFD leads with a +32.5% total return vs ICE's -20.4%. The 3-year compound annual growth rate (CAGR) favors NDAQ at 21.8% vs ICE's 10.4% — a key indicator of consistent wealth creation.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …CME logoCMECME Group Inc.WAFD logoWAFDWaFd, Inc.NDAQ logoNDAQNasdaq, Inc.
YTD ReturnYear-to-date+8.8%-11.8%+3.2%+17.1%-7.3%
1-Year ReturnPast 12 months+14.5%-20.4%+3.6%+32.5%+4.0%
3-Year ReturnCumulative with dividends+50.9%+34.6%+67.9%+37.6%+80.8%
5-Year ReturnCumulative with dividends+18.2%+30.9%+46.2%+29.5%+60.2%
10-Year ReturnCumulative with dividends+25.8%+195.3%+262.4%+91.9%+344.3%
CAGR (3Y)Annualised 3-year return+14.7%+10.4%+18.9%+11.2%+21.8%
NDAQ leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CME and WAFD each lead in 1 of 2 comparable metrics.

CME is the less volatile stock with a -0.28 beta — it tends to amplify market swings less than NDAQ's 0.71 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WAFD currently trades 99.9% from its 52-week high vs ICE's 74.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …CME logoCMECME Group Inc.WAFD logoWAFDWaFd, Inc.NDAQ logoNDAQNasdaq, Inc.
Beta (5Y)Sensitivity to S&P 5000.21x0.35x-0.28x0.66x0.71x
52-Week HighHighest price in past year$17.42$189.35$329.16$37.10$101.79
52-Week LowLowest price in past year$14.95$136.67$244.56$26.31$77.09
% of 52W HighCurrent price vs 52-week peak+98.2%+74.2%+81.9%+99.9%+87.4%
RSI (14)Momentum oscillator 0–10048.831.940.163.841.2
Avg Volume (50D)Average daily shares traded8K3.2M2.6M525K3.0M
Evenly matched — CME and WAFD each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — CME and WAFD each lead in 1 of 2 comparable metrics.

Analyst consensus: PROV as "Hold", ICE as "Buy", CME as "Hold", WAFD as "Hold", NDAQ as "Buy". Consensus price targets imply 38.0% upside for ICE (target: $194) vs -6.5% for PROV (target: $16). For income investors, CME offers the higher dividend yield at 4.05% vs NDAQ's 1.17%.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …CME logoCMECME Group Inc.WAFD logoWAFDWaFd, Inc.NDAQ logoNDAQNasdaq, Inc.
Analyst RatingConsensus buy/hold/sellHoldBuyHoldHoldBuy
Price TargetConsensus 12-month target$16.00$194.00$320.80$35.00$113.83
# AnalystsCovering analysts1036361136
Dividend YieldAnnual dividend ÷ price+3.3%+1.4%+4.1%+2.8%+1.2%
Dividend StreakConsecutive years of raises013151614
Dividend / ShareAnnual DPS$0.56$1.93$10.92$1.05$1.04
Buyback YieldShare repurchases ÷ mkt cap+4.1%+1.7%+0.3%+3.6%+1.2%
Evenly matched — CME and WAFD each lead in 1 of 2 comparable metrics.
Key Takeaway

CME leads in 1 of 6 categories (Income & Cash Flow). NDAQ leads in 1 (Total Returns). 4 tied.

Best OverallCME Group Inc. (CME)Leads 1 of 6 categories
Loading custom metrics...

PROV vs ICE vs CME vs WAFD vs NDAQ: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is PROV or ICE or CME or WAFD or NDAQ a better buy right now?

For growth investors, Nasdaq, Inc.

(NDAQ) is the stronger pick with 11. 1% revenue growth year-over-year, versus -1. 6% for WaFd, Inc. (WAFD). WaFd, Inc. (WAFD) offers the better valuation at 14. 1x trailing P/E (11. 4x forward), making it the more compelling value choice. Analysts rate Intercontinental Exchange, Inc. (ICE) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PROV or ICE or CME or WAFD or NDAQ?

On trailing P/E, WaFd, Inc.

(WAFD) is the cheapest at 14. 1x versus Nasdaq, Inc. at 28. 8x. On forward P/E, WaFd, Inc. is actually cheaper at 11. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CME Group Inc. wins at 1. 60x versus WaFd, Inc. 's 3. 69x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — PROV or ICE or CME or WAFD or NDAQ?

Over the past 5 years, Nasdaq, Inc.

(NDAQ) delivered a total return of +60. 2%, compared to +18. 2% for Provident Financial Holdings, Inc. (PROV). Over 10 years, the gap is even starker: NDAQ returned +344. 3% versus PROV's +25. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PROV or ICE or CME or WAFD or NDAQ?

By beta (market sensitivity over 5 years), CME Group Inc.

(CME) is the lower-risk stock at -0. 28β versus Nasdaq, Inc. 's 0. 71β — meaning NDAQ is approximately -354% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 166% for Provident Financial Holdings, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — PROV or ICE or CME or WAFD or NDAQ?

By revenue growth (latest reported year), Nasdaq, Inc.

(NDAQ) is pulling ahead at 11. 1% versus -1. 6% for WaFd, Inc. (WAFD). On earnings-per-share growth, the picture is similar: Nasdaq, Inc. grew EPS 60. 1% year-over-year, compared to -12. 3% for Provident Financial Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PROV or ICE or CME or WAFD or NDAQ?

CME Group Inc.

(CME) is the more profitable company, earning 62. 0% net margin versus 10. 4% for Provident Financial Holdings, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 14. 8% for PROV. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PROV or ICE or CME or WAFD or NDAQ more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, CME Group Inc. (CME) is the more undervalued stock at a PEG of 1. 60x versus WaFd, Inc. 's 3. 69x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, WaFd, Inc. (WAFD) trades at 11. 4x forward P/E versus 22. 6x for Nasdaq, Inc. — 11. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ICE: 38. 0% to $194. 00.

08

Which pays a better dividend — PROV or ICE or CME or WAFD or NDAQ?

All stocks in this comparison pay dividends.

CME Group Inc. (CME) offers the highest yield at 4. 1%, versus 1. 2% for Nasdaq, Inc. (NDAQ).

09

Is PROV or ICE or CME or WAFD or NDAQ better for a retirement portfolio?

For long-horizon retirement investors, CME Group Inc.

(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 28), 4. 1% yield, +262. 4% 10Y return). Both have compounded well over 10 years (CME: +262. 4%, WAFD: +91. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PROV and ICE and CME and WAFD and NDAQ?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: PROV is a small-cap income-oriented stock; ICE is a mid-cap quality compounder stock; CME is a mid-cap income-oriented stock; WAFD is a small-cap deep-value stock; NDAQ is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.